BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28932970)

  • 1. Computed tomography features of the major salivary glands after radioactive iodine ablation in patients with papillary thyroid carcinoma.
    Kim DW
    Radiol Med; 2018 Jan; 123(1):20-27. PubMed ID: 28932970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
    Kim DW
    Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.
    Soo Roh S; Wook Kim D; Jin Baek H
    AJR Am J Roentgenol; 2016 Nov; 207(5):1077-1081. PubMed ID: 27504709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Parotid and Submandibular Glands With Shear Wave Elastography Following Radioactive Iodine Therapy for Papillary Thyroid Carcinoma.
    Rahatli FK; Turnaoglu H; Iyidir OT; Kirnap NG; Haberal KM; Aydın E; Uslu N
    J Ultrasound Med; 2019 Feb; 38(2):357-362. PubMed ID: 30027680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
    Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
    Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-contrast-enhanced computed tomography attenuation in the parotid glands before radioiodine therapy for thyroid carcinoma could be a predictor of radiovulnerability.
    Sasaki T; Nabaa B; Takahashi K; Okizaki A; Ishitoya S
    Nucl Med Commun; 2015 Apr; 36(4):350-5. PubMed ID: 25501901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
    Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography features of papillary thyroid carcinomas.
    Kim DW
    J Comput Assist Tomogr; 2014; 38(6):936-40. PubMed ID: 25229203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Prevalence and Ultrasonography Features of Thyroglossal Duct Cyst in Adults According to Radioactive Iodine Ablation.
    Lee YJ; Kim DW; Shin GW; Park JY; Choo HJ; Park HK; Ha TK; Kim DH; Jung SJ; Park JS; Moon SH; Ahn KJ; Baek HJ
    Med Sci Monit; 2019 Dec; 25():9538-9546. PubMed ID: 31837133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer.
    Markitziu A; Lustmann J; Uzieli B; Krausz Y; Chisin R
    Oral Surg Oral Med Oral Pathol; 1993 Mar; 75(3):318-22. PubMed ID: 8469542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography-Detected Central Lymph Node Metastasis in Ultrasonography Node-Negative Papillary Thyroid Carcinoma: Is It Really Significant?
    Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2017 Feb; 24(2):442-449. PubMed ID: 27624581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
    Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
    Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Wu X; Gu H; Gao Y; Li B; Fan R
    Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic features of cervical lymph nodes after thyroidectomy for papillary thyroid carcinoma.
    Kim DW; Choo HJ; Lee YJ; Jung SJ; Eom JW; Ha TK
    J Ultrasound Med; 2013 Jul; 32(7):1173-80. PubMed ID: 23804339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma.
    Lee DW; Ji YB; Sung ES; Park JS; Lee YJ; Park DW; Tae K
    Eur J Surg Oncol; 2013 Feb; 39(2):191-6. PubMed ID: 22863305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
    Rosario PW; Mourão GF; dos Santos JB; Calsolari MR
    Thyroid; 2014 Mar; 24(3):533-6. PubMed ID: 24067080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
    Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
    Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.